The scheme was launched last year for pharma companies to modernize ... Act to make it mandatory for companies to follow Good Manufacturing Practices (GMP), a key step to ensuring the quality ...
The Committee was disturbed to find that prosecutions and arrests remain disproportionately low despite the high detection of ...
1 个月
Asian News International on MSNTimeline for Small Pharma Manufacturers' compliance with revised schedule 'M' extendedNew Delhi [India], February 13 (ANI): The Ministry of Health & Family Welfare has conditionally extended the due date for implementation of revised Schedule M (Good Manufacturing Practices ...
Micro, small and medium enterprises (MSMEs) with revenue of less than ₹ 250 crore have to submit an application before the ...
New Delhi Emcure Pharmaceuticals on Wednesday said the US health regulator has issued two observations after inspecting its Pune-based active pharmaceutical ingredients (API) manufacturing facility.
--(BUSINESS WIRE)--LGM Pharma, a leading provider of tailored ... ensuring compliance with FDA regulations and current good manufacturing practices (cGMP). The site will remain fully operational ...
This investment comes as LGM Pharma experiences sustained growth in prescription drug projects, including 505(b)(2) and Abbreviated New Drug Application (ANDA) programs. The Rosenberg facility ...
23 天
News-Medical.Net on MSNLGM Pharma invests $6 M in U.S. drug manufacturing capabilities for liquids, suspensions ...LGM Pharma, a leading provider of tailored API and CDMO services for the full drug product lifecycle, today announced an investment of over $6 million to expand its Rosenberg, Texas manufacturing ...
Astellas Pharma and Yaskawa Electric have signed a definitive agreement to establish ... expand its use to other facilities and develop a Good Manufacturing Practices (GMP) cell manufacturing platform ...
LGM Pharma invests $6 mn in US drug manufacturing facility to increase capacity for liquid, suspension, semi-solid & suppository drug products: Boca Raton, Florida Saturday, March ...
Zhejiang Langhua Pharmaceutical Co., Ltd. ('Langhua Pharmaceutical'), a wholly-owned subsidiary of Viva Biotech Holdings ('Viva Biotech'), underwent a cGMP (Current Good Manufacturing Practices) ...
The sanction involved the revocation of the Good Manufacturing Practices (GMP) certification of the company. It has further directed Samos Pharma, a Ghanaian importer, to terminate all ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果